Board/Management Information • Apr 20, 2021
Board/Management Information
Open in ViewerOpens in native device viewer
Rue Haute 4 • 1457 Walhain (Belgium) • +32476243611 • [email protected]
Results-oriented, Biopharmaceutical Professional with 20+ years' experience in sales, marketing, business development, pricing, access, policy and communication.
Key skills include:
Leading the teams responsible for Patient Access and Pricing, HEOR, Patient Affairs, Governmental Affairs and Communication.
Negotiation and signing of innovative multi-year contracts with authorities for complex therapeutic domains such as oncology, providing first in class early access to patients.
Member of the MSD Belux Leadership Team.
| Country Lead, Luxembourg | 2014 – 2016 |
|---|---|
| Head of cross-functional team with P&L responsibility. | |
| Chairman of the Board of APL | 2016 |
Responsible for analysis, strategic decisions (incl access, pricing, business development), action plans and implementation in cross-functional teams in order to deliver up to the established budgets. Broad experience in Marketing in different life-cycle stages and in multiple therapeutic domains: Launch products (Januvia, Janumet), mature products (Ezetrol, Inegy, Nuvaring, Implanon, Arcoxia, Fosavance) and off-patent products (Nasonex, Aerius, Mercilon, Marvelon, Cerazette).
Responsibilities including strategic planning, budget management, people management, launch of first in class products.
Baxter, Brussels 1996 Summer intern, Eu Pricing Department
Project manager in the department 'Discovery': responsible for the development of off-patent drug commercial opportunities.
EDUCATION
| Degree in Business and Administration | 1994-1995 |
|---|---|
| Université Catholique de Louvain, Louvain-La-Neuve | |
| Master of Pharmacy Katholieke Universiteit Leuven, Leuven |
1991-1994 |
| Bachelor of Pharmacy | 1989-1991 |
| Faculté Notre Dame de la Paix, Namur |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.